The current valuation score of NextCure Inc is 7.58, ranking 209 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.10, which is -97.90% below the recent high of -0.00 and -1043.70% above the recent low of -1.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.